Toll Free: 1-888-928-9744
Published: Oct, 2016 | Pages:
110 | Publisher: Gen Consulting Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Letrozole�(INN, trade name�Femara) is an oral non-steroidal�aromatase inhibitor�for the treatment of hormonally-responsive�breast cancer�after surgery. This report provides detailed analysis of worldwide markets for Letrozole (CAS 112809-51-5) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Letrozole (CAS 112809-51-5) market and further lays out an analysis of the factors influencing the supply/demand for Letrozole (CAS 112809-51-5), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. GCC's report, Global Letrozole (CAS 112809-51-5) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Letrozole (CAS 112809-51-5) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Letrozole (CAS 112809-51-5) market are Novartis (Swizerlands), Shilpa Ltd (India), Natco (India), Sunpharma (India), TEVA (Israel), Synthon (Netherlands), Zhejiang Hisun (China), Xieli Pharma (China), Venture Pharma (China), among others. The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Letrozole (CAS 112809-51-5) industry has been provided.
Table of Contents
Part 1. Scope of Report 1.1 Methodology 1.2 Geographic Scope 1.3 Years Considered Part 2. Introduction 2.1 Definition 2.2 Current Scenario 2.2 Future Scenario Part.3 Value Chain Analysis 3.1 Upstream 3.2 Downstream Part 4. Manufacture 4.1 Manufacturing Process 4.2 Issues and Trends 4.3 Manufacturing Costs Part 5. Worldwide Key Vendors 5.1 Company A 5.1.1 Business Overview 5.1.2 Products Offered 5.1.3 Business Performance 5.2 Company B 5.3 Company C 5.4 Company D 5.5 Company E 5.6 Company F 5.7 Company G 5.8 Company H 5.9 Company I 5.10 Company J Part 6. Market Overview 6.1 Global Production Volume 2011-2016 6.2 Production Volume by Region 2011-2016 6.2.1 North America 6.2.2 EMEA 6.2.3 Asia-Pacific 6.2.4 ROW 6.3 Global Production Value 2011-2016 6.4 Production Value by Region 6.4.1 North America 6.4.2 EMEA 6.4.3 Asia-Pacific 6.4.4 ROW Part 7. Consumption Pattern 7.1 Regional Consumption 7.1.1 North America 7.1.2 EMEA 7.1.3 Asia-Pacific 7.1.4 ROW 7.2 Global Consumption by Application Part 8. Market Forecast 8.1 Market Size by Volume 8.1.1 North America 8.1.2 EMEA 8.1.3 Asia-Pacific 8.1.4 ROW 8.2 Market Size by Value 8.2.1 North America 8.2.2 EMEA 8.2.3 Asia-Pacific 8.2.4 ROW 8.3 Regional Consumption Forecast 8.3.1 North America 8.3.2 EMEA 8.3.3 Asia-Pacific 8.3.4 ROW 8.4 Consumption Forecast by Application Part 9. Market Dynamics 9.1 Market Drivers 9.2 Market Constraints 9.3 Market Strategies Part 10. Key Events 10.1 Mergers & Acquisitions 10.2 New Product Launches 10.3 Expansions 10.4 Other Developments List of Tables and Figures
Figure Global Letrozole (CAS 112809-51-5) Production Volume (Unit) 2011-2016 Figure Global Letrozole (CAS 112809-51-5) Production Value (M USD) 2011-2016 Figure Top 10 Letrozole (CAS 112809-51-5) Vendors Production Volume Share 2015 Figure Top 10 Letrozole (CAS 112809-51-5) Vendors Production Value Share 2015 Figure Regional Letrozole (CAS 112809-51-5) Production (Unit) 2015 Figure Regional Letrozole (CAS 112809-51-5) Production Value (M USD) 2015 Table Raw Material Materials Suppliers Figure Global Letrozole (CAS 112809-51-5) Consumption Pattern 2015 Figure Manufacturing Cost Structure Figure Company A Letrozole (CAS 112809-51-5) Products Table Company A Financial Performance 2011-2016 Figure Company A Market Share 2011-2016 Figure Company B Letrozole (CAS 112809-51-5) Products Table Company B Financial Performance 2011-2016 Figure Company B Market Share 2011-2016 Figure Company C Letrozole (CAS 112809-51-5) Products Table Company C Financial Performance 2011-2016 Figure Company C Market Share 2011-2016 Figure Company D Letrozole (CAS 112809-51-5) Products Table Company D Financial Performance 2011-2016 Figure Company D Market Share 2011-2016 Figure Company E Letrozole (CAS 112809-51-5) Products Table Company E Financial Performance 2011-2016 Figure Company E Market Share 2011-2016 Figure Company F Letrozole (CAS 112809-51-5) Products Table Company F Financial Performance 2011-2016 Figure Company F Market Share 2011-2016 Figure Company G Letrozole (CAS 112809-51-5) Products Table Company G Financial Performance 2011-2016 Figure Company G Market Share 2011-2016 Figure Company H Letrozole (CAS 112809-51-5) Products Table Company H Financial Performance 2011-2016 Figure Company H Market Share 2011-2016 Figure Company I Letrozole (CAS 112809-51-5) Products Table Company I Financial Performance 2011-2016 Figure Company I Market Share 2011-2016 Figure Company J Letrozole (CAS 112809-51-5) Products Table Company J Financial Performance 2011-2016 Figure Company J Market Share 2011-2016 Table Global Key Letrozole (CAS 112809-51-5) Vendors Production (Unit) 2011-2016 Table Global Key Letrozole (CAS 112809-51-5) Vendors Production Share 2011-2016 Figure Global Letrozole (CAS 112809-51-5) Capacity & Production (Unit), Capacity Utilization 2011-2016 Figure Global Top 10 Letrozole (CAS 112809-51-5) Vendors Production (Unit) 2011-2016 Table Global Top 10 Letrozole (CAS 112809-51-5) Vendors Production (Unit) 2011 Table Global Top 10 Letrozole (CAS 112809-51-5) Vendors Production (Unit) 2012 Table Global Top 10 Letrozole (CAS 112809-51-5) Vendors Production (Unit) 2013 Table Global Top 10 Letrozole (CAS 112809-51-5) Vendors Production (Unit) 2014 Table Global Top 10 Letrozole (CAS 112809-51-5) Vendors Production (Unit) 2015 Table Global Top 10 Letrozole (CAS 112809-51-5) Vendors Production (Unit) 2016 Figure Letrozole (CAS 112809-51-5) Production Volume (Unit) 2011-2016 Table Global Production Volume (Unit) 2011-2016 Table Global Production Volume Share 2011-2016 Figure North America Letrozole (CAS 112809-51-5) Capacity & Production (Unit) Figure North America Production Share Trend Figure EMEA Letrozole (CAS 112809-51-5) Capacity & Production (Unit) Figure EMEA Production Share Trend Figure Asia-Pacific Letrozole (CAS 112809-51-5) Capacity & Production (Unit) Figure Asia-Pacific Production Share Trend Figure ROW Letrozole (CAS 112809-51-5) Capacity & Production (Unit) Figure ROW Production Share Trend Change Figure Global Letrozole (CAS 112809-51-5) Production Value (M USD), Growth Rate Table Global Key Letrozole (CAS 112809-51-5) Vendors Production Value (M USD) 2011-2016 Table Global Key Letrozole (CAS 112809-51-5) Vendors Production Value Share 2011-2016 Figure Global Top 10 Letrozole (CAS 112809-51-5) Vendors Production Value (M USD) 2011-2016 Table Global Top 10 Letrozole (CAS 112809-51-5) Vendors Production Value (M USD) 2011 Table Global Top 10 Letrozole (CAS 112809-51-5) Vendors Production Value (M USD) 2012 Table Global Top 10 Letrozole (CAS 112809-51-5) Vendors Production Value (M USD) 2013 Table Global Top 10 Letrozole (CAS 112809-51-5) Vendors Production Value (M USD) 2014 Table Global Top 10 Letrozole (CAS 112809-51-5) Vendors Production Value (M USD) 2015 Table Global Top 10 Letrozole (CAS 112809-51-5) Vendors Production Value (M USD) 2016 Figure Letrozole (CAS 112809-51-5) Prices (USD/Ton) 2016 Figure Letrozole (CAS 112809-51-5) Gross Margin 2016 Figure Letrozole (CAS 112809-51-5) Production Value (M USD) By Region 2011-2016 Table Global Letrozole (CAS 112809-51-5) Production Value (M USD) 2011-2016 Table Global Letrozole (CAS 112809-51-5) Production Value Share 2011-2016 Figure North America Production Value (M USD), Growth Rate Figure North America Letrozole (CAS 112809-51-5) Production Value Share Trend Figure EMEA Production Value (M USD), Growth Rate Figure EMEA Letrozole (CAS 112809-51-5) Production Value Share Trend Figure Asia-Pacific Production Value (M USD), Growth Rate Figure Asia-Pacific Letrozole (CAS 112809-51-5) Production Value Share Trend Figure ROW Production Value (M USD), Growth Rate Figure ROW Letrozole (CAS 112809-51-5) Production Value Share Trend Figure Global Letrozole (CAS 112809-51-5) Consumption Volume (Unit) 2015 Table Regional Letrozole (CAS 112809-51-5) Consumption Volume (Unit) 2011-2016 Table Regional Letrozole (CAS 112809-51-5) Consumption Volume Share 2011-2016 Figure Letrozole (CAS 112809-51-5) Consumption in North America 2011-2016 Figure Letrozole (CAS 112809-51-5) Consumption in EMEA 2011-2016 Figure Letrozole (CAS 112809-51-5) Consumption in Asia-Pacific 2011-2016 Figure Letrozole (CAS 112809-51-5) Consumption in ROW 2011-2016 Figure Global Letrozole (CAS 112809-51-5) Consumption Volume (Unit) 2016 Table Global Letrozole (CAS 112809-51-5) Consumption Volume (Unit) 2011-2016 Table Global Letrozole (CAS 112809-51-5) Consumption Volume Share 2011-2016 Figure Global Letrozole (CAS 112809-51-5) Production (Unit) Forecast 2016-2021 Table Global Letrozole (CAS 112809-51-5) Production (Unit) 2016-2021 Table Global Letrozole (CAS 112809-51-5) Production Share 2016-2021 Figure North Letrozole (CAS 112809-51-5) Production (Unit) Forecast 2016-2021 Figure EMEA Letrozole (CAS 112809-51-5) Production (Unit) Forecast 2016-2021 Figure Asia-Pacific Letrozole (CAS 112809-51-5) Production (Unit) Forecast 2016-2021 Figure ROW Letrozole (CAS 112809-51-5) Production (Unit) Forecast 2016-2021 Figure Global Letrozole (CAS 112809-51-5) Revenue (M USD) Forecast 2016-2021 Table Global Letrozole (CAS 112809-51-5) Revenue (M USD) 2016-2021 Table Global Letrozole (CAS 112809-51-5) Revenue Share 2016-2021 Figure North America Letrozole (CAS 112809-51-5) Revenue (M USD) Forecast 2016-2021 Figure EMEA Letrozole (CAS 112809-51-5) Revenue (M USD) Forecast 2016-2021 Figure Asia-Pacific Letrozole (CAS 112809-51-5) Revenue (M USD) Forecast 2016-2021 Figure ROW Letrozole (CAS 112809-51-5) Revenue (M USD) Forecast 2016-2021 Figure Global Letrozole (CAS 112809-51-5) Consumption Volume (Unit) 2016-2021 Table Global Letrozole (CAS 112809-51-5) Consumption Volume (Unit) 2016-2021 Table Global Letrozole (CAS 112809-51-5) Consumption Volume Share 2016-2021 Figure North America Letrozole (CAS 112809-51-5) Consumption (Unit) Forecast Figure EMEA Letrozole (CAS 112809-51-5) Consumption (Unit) Forecast Figure Asia-Pacific Letrozole (CAS 112809-51-5) Consumption (Unit) Forecast Figure ROW Letrozole (CAS 112809-51-5) Consumption (Unit) Forecast Figure Global Letrozole (CAS 112809-51-5) Consumption Volume (Unit) 2021 Table Global Letrozole (CAS 112809-51-5) Consumption Volume (Unit) 2016-2021 Table Global Letrozole (CAS 112809-51-5) Consumption Volume Share 2016-2021 Table Key Strategies for Letrozole (CAS 112809-51-5) Multinational Corporations Table Key Strategies for Letrozole (CAS 112809-51-5) Emerging-Market Players
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.